RYBELSUS 14 MG
RYBELSUS 14 MG contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used along with diet and exercise to help improve blood sugar control in adults with type 2 diabetes. It works by enhancing glucose-dependent insulin release, reducing glucagon secretion, and slowing gastric emptying, which can help regulate blood glucose levels. RYBELSUS 14 MG is an oral tablet formulation designed for once-daily administration as prescribed by a healthcare professional. The medicine should be taken exactly according to the prescribed instructions, particularly regarding timing in relation to food and other oral medicines. It may help support better glycemic control when used as part of an appropriate diabetes-management plan. Common side effects can include nausea, diarrhea, decreased appetite, vomiting, and abdominal discomfort. Patients should discuss their medical history and other medicines with their healthcare professional before using RYBELSUS. It is a prescription medicine and should be used only under appropriate medical supervision. Phoenix Exim supplies pharmaceutical products from India for international B2B enquiries and export requirements. We support medicine export enquiries from India to the USA, UK, Canada, Australia, Singapore, and South Korea.
CONTACT PHOENIX EXIM
Contact No. / WhatsApp: +91-9307610860 & +91-9860818372
Email: phoenixexim2000@gmail.com
